From MD&AIntellectual Property Portfolio Growth Theralase® received the following decisions to grant a patent in 2022: Country Patent Title Brazil Metal-Based Thiophene Photodynamic Compounds and Their Use Metal-Based Thiophene Photodynamic Compounds and Their Use The Mechanism of Action (“MOA”) of the patented Theralase® PDCs involves selective localization of the PDC inside the cancer cells of interest and then activating it by laser light to produce effective free radicals, singlet oxygen and ROS, temporally and spatially to destroy the cancer cells, with minimum impact on healthy cells. Compositions of the invention include tunable metal-based thiophene photodynamic compounds useful as therapeutic agents and as in vivo diagnostic agents for treating or preventing diseases that involve hyperproliferating cell etiology including cancer and diseases associated with hyperproliferating cells. The compositions are also useful for treating infectious diseases and for pathogen disinfection.